The detection of risk factors in the early stage of disease will help the patient to improve and reduce the morbidity rate
While GLP-1s are mainly known for their impact on glycaemic control and weight management, they play a role beyond, with effects confirmed or at least suspected on cardiovascular risk, kidney disease, obstructive sleep apnoea and osteoarthritis
When we eat, GLP-1 is released, signaling our brain to reduce hunger and make us feel full
(1997) High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells
Of these, permeation enhancers are the most widely tested approach to improve oral absorption of peptides, due to the relative ease with which they can be incorporated into formulations compared with nanotechnology or device-based systems [43, 46]